|
|
Our transition into fall and into a new year of programming continues here at Life Sciences BC. Our AGM last week saw arrivals and departures. Max Blouw, Kevin Chaplin, Bob Dawson, and I were elected to the Board of Directors. Nancy Harrison and Dr. Gavin Stuart, who have both made significant contributions to the organization and its overall management in the last several years, departed. LSBC thanks Nancy and Gavin for their years of guidance and I look forward to their continuing leadership in the BC life sciences sector.
At the subsequent Board of Directors meeting, it was announced that Scott Phillips will continue as Chair, Board of Directors with Ali Ardakani remaining as Vice Chair. Rajveer Hundal will stay on as Treasurer. You can see full details of our 2021/2022 Board here.
|
|
Luckily, Bloom Burton’s Canada in Science September is not behind a paywall. And neither is our annual Life Sciences magazine. Published in partnership with Business in Vancouver, the issue will be on the stands from today, with the digital version added to our Publications page shortly after. Without giving spoilers, this year’s magazine takes a look at breakthrough innovation, real estate, and building a bigger sector propelled by the COVID-19 pandemic, with a side order of psychedelics. Copies will be available to collect from our downtown office if you’d like to drop by, suitably masked of course!
If you’re still in the mood to celebrate, why not join me at our annual Life Sciences BC Awards Ceremony, presented by FARRIS. It takes place online this week on Thursday, September 23rd at 2pm. Tickets here.
-Wendy Hurlburt
|
|
|
|
Join us on Thursday September 23rd for the 23rd Annual Life Sciences BC Awards presented by FARRIS. This event is an opportunity to celebrate the life science sector’s many achievements amongst peers, family, and friends. As Canada’s fastest-growing life sciences sector, our British Columbia ecosystem has never been stronger seeing unprecedented momentum in scientific discovery, innovation, and attraction of capital and talent.
|
|
|
|
The IHE Life Sciences Market Access Program supports Alberta and British Columbia-based life sciences companies with promising, market-ready healthcare technology that are currently seeking market access in Canada or beyond. With funding support from the Federal Government, the Institute of Health Economics (IHE) is pleased to release a Call for Expressions of Interest from organizations that would like to participate in a project intended to strengthen their market access opportunity. READ MORE
Deadline: October 5, 2021
|
|
|
|
InMed Pharmaceuticals Inc., a leader in the manufacturing and clinical development of rare cannabinoids, today announced that it has entered into a definitive agreement to acquire BayMedica Inc., a private company based in the US that specializes in the manufacturing and commercialization of rare cannabinoids. The Definitive Agreement follows a previously signed letter of intent announced on June 29, 2021. The transaction, which is subject to certain standard closing conditions, is expected to close in the coming weeks. READ MORE
|
|
|
|
AbCellera, a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc., a biotechnology company with a proprietary platform for generating recombinant human ion channels and other transmembrane proteins, in an all-cash transaction that includes an upfront payment, the potential for payments based on the achievement of technical milestones, and additional development and commercial milestone payments related to successfully developed therapeutics. READ MORE
|
|
|
|
Join StarFish Medical on Thursday, September 23, 2021 for a f ree, live, 90-minute Medical Device Playbook Event featuring Francois Michelon, CEO, ENDRA Life Sciences, and Steven Plymale, Former CEO, MyndTec and Profound Medical, discuss lessons learned from taking their medical device companies public. READ MORE
|
|
|
|
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company with an innovative drug delivery platform technology, today announced that it has started screening patients for inclusion into its Phase 2 trial, which is evaluating EP-104IAR’s efficacy and safety as a treatment for knee osteoarthritis. READ MORE
|
|
|
|
We are proud to announce that XCO Tech Inc. and our partners on the international R&D&I PARTNER Project have been awarded the 2021 ITEA Award of Excellence. READ MORE
|
|
|
|
We are very pleased that our collaboration with Mohsen Akbari at University of Victoria has now entered into its second phase with a new 3-year grant funding commitment from Mitacs, a new agreement on a key patent filed with the the USPTO, and exciting plans to optimize certain nanoparticle technologies for next-gen manufacturing of RepliCel's cell therapies. READ MORE
|
|
|
|
BIOTECanada invites you to MEET BIONATION. Learn more about Canadian biotech excellence and what life sciences is already doing for healthcare and for the future. READ MORE
|
|
 |
Brighton Group Health is a boutique management consulting firm focused on growth strategies, value creation and operational transformation. They brings experience from the public and private health sectors to ensure that their solutions create value for both your organization and your clients. Their scope encompasses the entire healthcare ecosystem, integrating strategy, policy, and tech innovation.
|
|
|
|
Claris Healthcare provides a platform for the delivery of healthcare into a person’s home. They offer Claris Companion for providing social care – linking family caregivers to isolated senior family members; Claris Continuum provides advanced and flexible remote patient monitoring and helps home care providers manage chronic conditions in the patient’s home.
|
|
|
|
|
|
PERSPECTIVES ON GLOBAL HEALTHCARE INNOVATION |
What’s driving innovation in life science and healthcare? SVB is committed to serving the ecosystem by providing industry-leading reports featuring proprietary analysis and targeted outlooks to help companies and investors achieve their goals. Twice a year we publish deep-dive analyses describing fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies. Our deep relationships with top life science and healthcare entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank. To find out more about Silicon Valley Bank click here.
|
|
|
|
Post A Job on the LSBC Website! |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish. After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? Contact Peter McLoughlin - talent@lifesciencesbc.ca
|
|
|
|
|
|
|
